Filing Details
- Accession Number:
- 0001354488-16-006306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-19 16:30:24
- Reporting Period:
- 2016-02-02
- Filing Date:
- 2016-02-19
- Accepted Time:
- 2016-02-19 16:30:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
34956 | Tenax Therapeutics Inc. | TENX | Services-Commercial Physical & Biological Research (8731) | 262593535 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1597439 | P. James Mitchum | C/O Tenax Therapeutics, Inc. One Copley Parkway, Suite 490 Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-02 | 5,100 | $2.68 | 5,100 | No | 4 | P | Indirect | By James P Mitchum Teresa V Mitchum Revocable Living Trust |
Common Stock | Acquisiton | 2016-02-03 | 13,900 | $2.65 | 19,000 | No | 4 | P | Indirect | By James P Mitchum Teresa V Mitchum Revocable Living Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By James P Mitchum Teresa V Mitchum Revocable Living Trust |
No | 4 | P | Indirect | By James P Mitchum Teresa V Mitchum Revocable Living Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.69. The reporting person undertakes to provide to Tenax Therapeutics, Inc. (the ?Company?), any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.69.